Medicare Enrolled

Dr. Marina Konopleva, M.D. PHD

Hematology & Oncology · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Consulting-driven
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
In practice since 2006 (19 years)
NPI: 1518063486 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Konopleva from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Konopleva? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Konopleva

Dr. Marina Konopleva is a hematology & oncology in Houston, TX, with 19 years in practice. Based on federal Medicare data, Dr. Konopleva performed 120 Medicare services across 20 unique beneficiaries.

Between the years covered by Open Payments, Dr. Konopleva received a total of $104,000 from 26 pharmaceutical and/or device companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Konopleva is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 120 Medicare services$ $104,000 industry payments

Medicare Practice Summary

Medicare Utilization ↗
120
Medicare services
Bottom 9% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
20
Unique beneficiaries
$104
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, high complexity120$104$625
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$104,000
Total received (2018-2024)
Avg $14,857/year across 7 years
Top 6% in TX for hematology & oncology
26
Companies
102
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$66,559 (64.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$36,286 (34.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,155 (1.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,104
2023
$18,330
2022
$9,658
2021
$15,554
2020
$1,361
2019
$17,153
2018
$28,839

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
F. Hoffmann-La Roche AG
$17,651
ABBVIE INC.
$17,443
Janssen Global Services, LLC
$16,258
Hikma Pharmaceuticals USA
$12,926
AbbVie, Inc.
$7,042
West-Ward Pharmaceuticals
$6,924
Stemline Therapeutics Inc.
$3,458
Gilead Sciences, Inc.
$3,270
Amgen Inc.
$2,956
Legend Biotech USA Inc.
$2,955
Adaptive Biotechnologies Corporation
$2,546
Novartis Pharmaceuticals Corporation
$2,513
SERVIER PHARMACEUTICALS LLC
$1,700
BeiGene USA, Inc.
$1,625
Genentech USA, Inc.
$1,433
Hoffmann-La Roche Limited
$1,406
Celgene Corporation
$1,000
PFIZER INC.
$171
Servier Pharmaceuticals LLC
$155
Astellas Pharma US Inc
$118
AbbVie Inc.
$117
SANOFI US SERVICES INC.
$109
Genentech, Inc.
$106
AstraZeneca UK Limited
$55
Takeda Pharmaceuticals U.S.A., Inc.
$42
Rigel Pharmaceuticals, Inc.
$22
Top 3 companies account for 49.4% of total payments
Associated products mentioned in payments ›
Blincyto · ELZONRIS · IMBRUVICA · MYLOTARG · Non-Covered Product · Oncology TA · Rezlidhia · TECENTRIQ · TIBSOVO · Tibsovo · VENCLEXTA · Venclexta · Xospata · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (64%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 6% for hematology & oncology in TX.

Equivalent to $86,667 per 100 Medicare services performed
Looking for a hematology & oncology in Houston?
Compare hematology & oncologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncologys nearby

Geographic Context

Hematology & Oncologys within 10 mi
202
Per 100K population
4.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry✓ NPPESWeekly updates
Medicare Enrollment✓ PECOSMonthly updates
Practice Data✓ Medicare Util.Annual (CY lag)
Industry Payments✓ Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Konopleva is a mixed practice specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 6%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Konopleva experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Konopleva performed 120 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Konopleva receive payments from pharmaceutical companies?
Yes. Dr. Konopleva received a total of $104,000 from 26 companies across 102 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Konopleva's costs compare to other hematology & oncologys in Houston?
Dr. Konopleva's average Medicare payment per service is $104. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Konopleva) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncologys in Houston
Browse hematology & oncologys in Houston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
F. Hoffmann-La Roche AG Payments to Doctors
See all physicians who received payments from F. Hoffmann-La Roche AG.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC..
By company
Janssen Global Services, LLC Payments to Doctors
See all physicians who received payments from Janssen Global Services, LLC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →